Genetically modified goat milk tested to protect cancer patients after transplant
NCT ID NCT04177004
Summary
This early-stage study is testing whether drinking milk from genetically engineered goats can help prevent a dangerous complication called graft-versus-host disease (GVHD) in blood cancer patients. The milk contains a human enzyme that may promote healthy gut bacteria and reduce infections. Researchers will enroll 53 patients undergoing a donor stem cell transplant to see if the milk is safe and tolerable to drink daily.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.